Experience

BioIVT

• United States
• Biotechnology Research
• 200 - 300 Employee

• Global Director, Technical Sales Specialist ADMET

  • Feb 2023 - Present

• Business Development Manager

  • Jan 2018 - Mar 2023



Spot On Sciences

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Director of Research and Development

  • Sep 2014 - Dec 2017

  As Research Manager at Spot On Sciences, my role involves elucidating mechanisms for analysis of blood-based biomarkers associated with cardiovascular disease. I utilize molecular biology techniques to conduct research on analysis of micro RNAs and their regulation of circadian rhythm pathways. We are optimizing the dried blood spot technology for identification of circulating biomarkers in whole blood or plasma. As Research Manager at Spot On Sciences, my role involves elucidating mechanisms for analysis of blood-based biomarkers associated with cardiovascular disease. I utilize molecular biology techniques to conduct research on analysis of micro RNAs and their regulation of circadian rhythm pathways. We are optimizing the dried blood spot technology for identification of circulating biomarkers in whole blood or plasma.



Roche

• Switzerland
• Biotechnology Research
• 700 & Above Employee

• Principal Scientist

  • Oct 2009 - Mar 2013

  As a principal scientist at Hoffman-La Roche, Inc. Robert serves as the leader of the early ADME Mechanistic Enzymology group within the Non Clinical Safety department. Keen ability to strategically plan, design, and supervise experimental strategies or research programs, that contribute to the development of novel reagents and processes that support mechanistic analysis of small molecule drug candidates. Head of the CYP induction CoE lab that supports global Roche discovery and developmental… Show more As a principal scientist at Hoffman-La Roche, Inc. Robert serves as the leader of the early ADME Mechanistic Enzymology group within the Non Clinical Safety department. Keen ability to strategically plan, design, and supervise experimental strategies or research programs, that contribute to the development of novel reagents and processes that support mechanistic analysis of small molecule drug candidates. Head of the CYP induction CoE lab that supports global Roche discovery and developmental projects. Effectively serve as drug metabolism consult to project teams regarding the risk of clinical drug-drug interactions via induction of drug metabolizing enzymes. Show less As a principal scientist at Hoffman-La Roche, Inc. Robert serves as the leader of the early ADME Mechanistic Enzymology group within the Non Clinical Safety department. Keen ability to strategically plan, design, and supervise experimental strategies or research programs, that contribute to the development of novel reagents and processes that support mechanistic analysis of small molecule drug candidates. Head of the CYP induction CoE lab that supports global Roche discovery and developmental… Show more As a principal scientist at Hoffman-La Roche, Inc. Robert serves as the leader of the early ADME Mechanistic Enzymology group within the Non Clinical Safety department. Keen ability to strategically plan, design, and supervise experimental strategies or research programs, that contribute to the development of novel reagents and processes that support mechanistic analysis of small molecule drug candidates. Head of the CYP induction CoE lab that supports global Roche discovery and developmental projects. Effectively serve as drug metabolism consult to project teams regarding the risk of clinical drug-drug interactions via induction of drug metabolizing enzymes. Show less



CellzDirect

• Biotechnology Research
• 1 - 100 Employee

• Project Director

  • Jul 2007 - Oct 2009

  As a study director at CellzDirect, Inc., Dr. Taylor is responsible for managing, designing, and implementing in vitro drug metabolism studies including cytochrome P450 induction studies, cytochrome P450 inhibition studies, and cytochrome P450 reaction phenotyping studies. As a study director at CellzDirect, Inc., Dr. Taylor is responsible for managing, designing, and implementing in vitro drug metabolism studies including cytochrome P450 induction studies, cytochrome P450 inhibition studies, and cytochrome P450 reaction phenotyping studies.



Life Technologies

• United States
• Biotechnology Research
• 700 & Above Employee

• Study Director

  • 2007 - Oct 2009

  As a study director at Invitrogen Corporation, Dr. Taylor is responsible for managing, designing, and implementing in vitro drug metabolism studies including cytochrome P450 induction studies, cytochrome P450 inhibition studies, cytochrome P450 reaction phenotyping studies, plasma protein binding studies and drug-drug interaction studies. As a study director at Invitrogen Corporation, Dr. Taylor is responsible for managing, designing, and implementing in vitro drug metabolism studies including cytochrome P450 induction studies, cytochrome P450 inhibition studies, cytochrome P450 reaction phenotyping studies, plasma protein binding studies and drug-drug interaction studies.